Membrane Lipid Remodeling Takes Center Stage in Growth Factor Receptor-Driven Cancer Development

Enhanced growth factor signaling is a hallmark of cancer, allowing cancer cells to thrive in a challenging environment. In this issue of Cell Metabolism, Bi et al. (2019) identify LPCAT1, a key membrane lipid remodeling enzyme, as a central link between genetically driven growth factor receptor expression, signaling, and tumor growth, highlighting lipid remodeling as a therapeutic target in cancer.

Jaar van publicatie:2019

Toegankelijkheid:Open